Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
3238 | 2003 | 29.8 | 43% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
210 | 3 | IMMUNOLOGY//JOURNAL OF INTERFERON RESEARCH//NK CELLS | 51916 |
3238 | 2 | ARBIDOL//VOPROSY VIRUSOLOGII//COOPERAT MED | 2003 |
10796 | 1 | AUTOLOGOUS MIXED LYMPHOCYTE REACTION//AUTOLOGOUS MIXED LYMPHOCYTE REACTION AMLR//CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY | 1034 |
27897 | 1 | COOPERAT MED//ISOFATTY ACID//PORCINE BCL G | 218 |
28412 | 1 | ARBIDOL//VOPROSY VIRUSOLOGII//OMSK VET | 207 |
31467 | 1 | THYMOPENTIN ANALOGS//EXOGENOUS UBIQUITIN//EXTRACELLULAR UBIQUITIN | 152 |
33459 | 1 | CHONDROITIN SULFATE B CSB//HBS GENE//SERV CLIN MALAD INFECT | 124 |
33842 | 1 | AUTOREACTIVE LYMPHOCYTES T//COXSACKIEVIRUS A13//HUMAN ADENOVIRUS TYPE 6 | 119 |
35676 | 1 | JL1//HEMATOPOIET TUMOR//JL1 MONOCLONAL ANTIBODY | 93 |
37507 | 1 | ST 789//HYPOXANTHINE DERIVATIVES//HUMAN T LYMPHOBLASTIC CELLS | 56 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ARBIDOL | authKW | 154320 | 1% | 56% | 18 |
2 | VOPROSY VIRUSOLOGII | journal | 87984 | 6% | 5% | 114 |
3 | COOPERAT MED | address | 73764 | 1% | 44% | 11 |
4 | ST 789 | authKW | 63511 | 0% | 83% | 5 |
5 | ISOFATTY ACID | authKW | 48776 | 0% | 80% | 4 |
6 | THYMOPENTIN ANALOGS | authKW | 48776 | 0% | 80% | 4 |
7 | EXOGENOUS UBIQUITIN | authKW | 45729 | 0% | 100% | 3 |
8 | EXTRACELLULAR UBIQUITIN | authKW | 45729 | 0% | 100% | 3 |
9 | AUTOLOGOUS MIXED LYMPHOCYTE REACTION | authKW | 39302 | 0% | 37% | 7 |
10 | HISTOCOMPATIBILITY ANTIGEN | authKW | 36576 | 0% | 40% | 6 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Immunology | 22570 | 51% | 0% | 1015 |
2 | Rheumatology | 2169 | 6% | 0% | 125 |
3 | Virology | 1766 | 8% | 0% | 152 |
4 | Pathology | 515 | 5% | 0% | 104 |
5 | Medicine, Research & Experimental | 345 | 6% | 0% | 121 |
6 | Cell Biology | 332 | 9% | 0% | 172 |
7 | Medical Laboratory Technology | 234 | 2% | 0% | 41 |
8 | Medicine, General & Internal | 158 | 6% | 0% | 117 |
9 | Allergy | 153 | 1% | 0% | 30 |
10 | Microbiology | 95 | 4% | 0% | 88 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | COOPERAT MED | 73764 | 1% | 44% | 11 |
2 | OMSK VET | 30486 | 0% | 100% | 2 |
3 | BIOCHEM BIOTECHNOL TECH BIOCHEM | 15243 | 0% | 100% | 1 |
4 | CHS NACHWUCHSGRP CELLNETWORKS CLUSTER | 15243 | 0% | 100% | 1 |
5 | CNRS 5286U1052 | 15243 | 0% | 100% | 1 |
6 | CONTRACEPTIVES DEVICES POPULAT | 15243 | 0% | 100% | 1 |
7 | DAUGHTRY SURG SURG CRIT CARE | 15243 | 0% | 100% | 1 |
8 | DAUGHTRY SURG TRAUMA | 15243 | 0% | 100% | 1 |
9 | DEP HAEMATOL MOL MED | 15243 | 0% | 100% | 1 |
10 | DEWITT DAUGHTY FAMILY SURG | 15243 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | VOPROSY VIRUSOLOGII | 87984 | 6% | 5% | 114 |
2 | CELLULAR IMMUNOLOGY | 24867 | 6% | 1% | 113 |
3 | CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY | 20876 | 3% | 2% | 68 |
4 | JOURNAL OF CLINICAL & LABORATORY IMMUNOLOGY | 10712 | 1% | 3% | 28 |
5 | ZHURNAL MIKROBIOLOGII EPIDEMIOLOGII I IMMUNOBIOLOGII | 8972 | 2% | 1% | 43 |
6 | CLINICAL AND EXPERIMENTAL IMMUNOLOGY | 7541 | 4% | 1% | 75 |
7 | JOURNAL OF IMMUNOLOGY | 7406 | 8% | 0% | 163 |
8 | THYMUS | 5106 | 1% | 2% | 14 |
9 | EOS-RIVISTA DI IMMUNOLOGIA ED IMMUNOFARMACOLOGIA | 4719 | 1% | 2% | 13 |
10 | HUMAN IMMUNOLOGY | 3978 | 2% | 1% | 35 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ARBIDOL | 154320 | 1% | 56% | 18 | Search ARBIDOL | Search ARBIDOL |
2 | ST 789 | 63511 | 0% | 83% | 5 | Search ST+789 | Search ST+789 |
3 | ISOFATTY ACID | 48776 | 0% | 80% | 4 | Search ISOFATTY+ACID | Search ISOFATTY+ACID |
4 | THYMOPENTIN ANALOGS | 48776 | 0% | 80% | 4 | Search THYMOPENTIN+ANALOGS | Search THYMOPENTIN+ANALOGS |
5 | EXOGENOUS UBIQUITIN | 45729 | 0% | 100% | 3 | Search EXOGENOUS+UBIQUITIN | Search EXOGENOUS+UBIQUITIN |
6 | EXTRACELLULAR UBIQUITIN | 45729 | 0% | 100% | 3 | Search EXTRACELLULAR+UBIQUITIN | Search EXTRACELLULAR+UBIQUITIN |
7 | AUTOLOGOUS MIXED LYMPHOCYTE REACTION | 39302 | 0% | 37% | 7 | Search AUTOLOGOUS+MIXED+LYMPHOCYTE+REACTION | Search AUTOLOGOUS+MIXED+LYMPHOCYTE+REACTION |
8 | HISTOCOMPATIBILITY ANTIGEN | 36576 | 0% | 40% | 6 | Search HISTOCOMPATIBILITY+ANTIGEN | Search HISTOCOMPATIBILITY+ANTIGEN |
9 | UBIQUITIN FRAGMENTS | 34295 | 0% | 75% | 3 | Search UBIQUITIN+FRAGMENTS | Search UBIQUITIN+FRAGMENTS |
10 | 1 2 DIDEHYDROPROLINES | 30486 | 0% | 100% | 2 | Search 1+2+DIDEHYDROPROLINES | Search 1+2+DIDEHYDROPROLINES |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | BACH, HH , WONG, YM , LAPORTE, HM , GAMELLI, RL , MAJETSCHAK, M , (2016) PHARMACOLOGICAL TARGETING OF CHEMOKINE (C-X-C MOTIF) RECEPTOR 4 IN PORCINE POLYTRAUMA AND HEMORRHAGE MODELS.JOURNAL OF TRAUMA AND ACUTE CARE SURGERY. VOL. 80. ISSUE 1. P. 102 -110 | 23 | 66% | 0 |
2 | SUN, YX , HE, XJ , QIU, F , ZHU, X , ZHAO, MM , LI-LING, J , SU, XY , ZHAO, LM , (2013) PHARMACOKINETICS OF SINGLE AND MULTIPLE ORAL DOSES OF ARBIDOL IN HEALTHY CHINESE VOLUNTEERS.INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS. VOL. 51. ISSUE 5. P. 423-432 | 13 | 87% | 1 |
3 | BLAISING, J , POLYAK, SJ , PECHEUR, EI , (2014) ARBIDOL AS A BROAD-SPECTRUM ANTIVIRAL: AN UPDATE.ANTIVIRAL RESEARCH. VOL. 107. ISSUE . P. 84 -94 | 24 | 39% | 19 |
4 | WOLFLEVIN, R , AZUMA, T , AOKI, K , YAGAMI, Y , OKADA, H , (1993) SPECIFIC IGG AUTOANTIBODIES ARE POTENT INHIBITORS OF AUTOREACTIVE T-CELL RESPONSE TO PHYTOHEMAGGLUTININ-ACTIVATED T-CELLS.JOURNAL OF IMMUNOLOGY. VOL. 151. ISSUE 10. P. 5864-5877 | 27 | 69% | 10 |
5 | OSTERLAND, CK , STLOUIS, EA , (1992) IMMUNE REACTIVITY IN AGING - AUTOLOGOUS MIXED LYMPHOCYTE-RESPONSES.GERONTOLOGY. VOL. 38. ISSUE 6. P. 301-307 | 21 | 91% | 5 |
6 | GUPTA, S , (1983) AUTOLOGOUS MIXED LYMPHOCYTE-REACTION IN HEALTH AND DISEASE STATES IN MAN.VOX SANGUINIS. VOL. 44. ISSUE 5. P. 265-288 | 41 | 59% | 56 |
7 | WONG, YM , LAPORTE, HM , ALBEE, LJ , BAKER, TA , BACH, HH , VANA, PG , EVANS, AE , GAMELLI, RL , MAJETSCHAK, M , (2017) UBIQUITIN URINE LEVELS IN BURN PATIENTS.JOURNAL OF BURN CARE & RESEARCH. VOL. 38. ISSUE 1. P. E133 -E143 | 20 | 37% | 0 |
8 | GARCIA-COVARRUBIAS, L , MANNING, EW , SORELL, LT , PHAM, SM , MAJETSCHAK, M , (2008) UBIQUITIN ENHANCES THE TH2 CYTOKINE RESPONSE AND ATTENUATES ISCHEMIA-REPERFUSION INJURY IN THE LUNG.CRITICAL CARE MEDICINE. VOL. 36. ISSUE 3. P. 979-982 | 11 | 79% | 13 |
9 | SAINI, V , MARCHESE, A , MAJETSCHAK, M , (2010) CXC CHEMOKINE RECEPTOR 4 IS A CELL SURFACE RECEPTOR FOR EXTRACELLULAR UBIQUITIN.JOURNAL OF BIOLOGICAL CHEMISTRY. VOL. 285. ISSUE 20. P. 15566 -15576 | 18 | 41% | 48 |
10 | WINFIELD, JB , (1985) ANTI-LYMPHOCYTE ANTIBODIES IN SYSTEMIC LUPUS-ERYTHEMATOSUS.CLINICS IN RHEUMATIC DISEASES. VOL. 11. ISSUE 3. P. 523-549 | 34 | 62% | 32 |
Classes with closest relation at Level 2 |